Skip to main content
OpenTrials

Clinical trial condition

ALS

Explore clinical trials studying ALS. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

ALS trial results

Completed

Safety Study of Oral Edaravone Administered in Subjects With ALS

NCT04165824

Conditions
ALS
Locations
  • St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center Phoenix, Arizona, United States
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • Woodland Research Northwest Rogers, Arkansas, United States
  • Sutter Health San Francisco, California, United States
View all 53 locations
View Trial Details
Completed

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

NCT05568615

Conditions
ALS
Locations
  • National Hospital Organization Higashinagoya National Hospital Nagoya, Aichi-ken, Japan
  • National Hospital Organization Chibahigashi National Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Kagawa University Hospital Kita-gun, Kagawa-ken, Japan
View Trial Details
Completed

Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

NCT04259255

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • UCLA Als Clinic Los Angeles, California, United States
  • UC Davis Health Sacramento, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 20 locations
View Trial Details
Completed

Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)

NCT05508074

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Hôpital Neurologique Pierre Wertheimer Bron, France
  • APHM Hôpital La Timone Adultes SCE Maladies Neuromusculaires / SLA Marseille, France
  • CHU de Nantes - Hôpital Laennec Nantes, France
  • CHU de Toulouse - Hôpital Pierre-Paul Riquet Toulouse, France
View Trial Details
Completed

A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS

NCT05357950

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Lawson Health Research Institute London, Ontario, Canada
  • Tel Aviv Sourasky Medical Center Tel Aviv, Israel
  • IRCCS Istituti clinici Maugeri Milan, Italy
  • A.O.U. Citta della Salute e della Scienza di Torino Torino, Italy
View Trial Details

Related conditions